Michael Yee
Stock Analyst at UBS
(3.85)
# 1,972
Out of 5,133 analysts
1375
Total ratings
47.8%
Success rate
3.9%
Average return
Main Sectors:
Stocks Rated by Michael Yee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KOD Kodiak Sciences | Maintained: Buy | $120 → $150 | $109.34 | +37.19% | 17 | Nov 13, 2026 | |
| SRRK Scholar Rock Holding | Maintained: Buy | $60 | $46.60 | +28.76% | 17 | Nov 12, 2026 | |
| MBX MBX Biosciences | Reiterated: Buy | $90 | $57.72 | +55.93% | 7 | Nov 10, 2026 | |
| ORKA Oruka Therapeutics | Reiterated: Buy | $130 | $107.17 | +21.30% | 9 | Nov 10, 2026 | |
| MRNA Moderna | Rated: Hold | $150 → $225 | $248.69 | -9.53% | 72 | Nov 9, 2026 | |
| AMGN Amgen | Reiterated: Buy | $470 → $530 | $468.11 | +13.22% | 191 | Nov 4, 2026 | |
| PFE Pfizer | Reiterated: Hold | $27 → $30 | $29.45 | +1.87% | 11 | Nov 4, 2026 | |
| VRTX Vertex Pharmaceuticals | Reiterated: Buy | $615 → $640 | $547.03 | +17.00% | 132 | Nov 4, 2026 | |
| ABBV AbbVie | Rated: Hold | $275 → $295 | $294.98 | +0.01% | 9 | Nov 2, 2026 | |
| IVA Inventiva | Reiterated: Buy | $12 | $4.01 | +199.25% | 5 | Nov 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $175 → $195 | $169.73 | +14.89% | 192 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $1,425 → $1,625 | $1,437.29 | +13.06% | 9 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $270 → $300 | $253.40 | +18.39% | 174 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $32.72 | +52.84% | 4 | Oct 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $320 | $280.41 | +14.12% | 5 | Oct 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $175 | $147.18 | +18.90% | 9 | Oct 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $265 | $180.70 | +46.65% | 9 | Oct 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $35 | $13.30 | +163.16% | 1 | Oct 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $29.40 | +104.08% | 5 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $62.91 | +27.17% | 7 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $76 | $48.77 | +55.83% | 6 | Sep 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $55 | $31.84 | +72.74% | 1 | Sep 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $65 | $50.53 | +28.64% | 3 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $25 → $34 | $19.73 | +72.33% | 18 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $16.54 | +172.07% | 1 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $8.04 | +459.70% | 22 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.12 | +435.71% | 13 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $18 → $13 | $31.52 | -58.76% | 18 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $20 | $2.16 | +825.93% | 5 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $7 | $4.29 | +63.17% | 10 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $3.11 | +125.08% | 2 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $23.25 | +93.55% | 1 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 → $50 | $31.25 | +60.00% | 2 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 → $35 | $26.42 | +32.48% | 19 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $0.9001 | +788.79% | 4 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $30 → $28 | $25.81 | +8.49% | 5 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 → $55 | $31.65 | +73.78% | 13 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 → $3.5 | $3.79 | n/a | 8 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $32 → $6 | $8.73 | n/a | 48 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $18 | $8.09 | n/a | 3 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $145 → $8 | $1.61 | n/a | 6 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 → $1 | $11.71 | n/a | 34 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $70.70 | n/a | 2 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $46 → $10 | $0.5993 | n/a | 4 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $45 → $15 | $3.68 | n/a | 19 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $7 | $22.37 | n/a | 8 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $31 | $22,005.00 | n/a | 3 | Dec 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 → $1 | $1.09 | n/a | 3 | Jul 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.5 | $1.05 | n/a | 1 | Jul 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $4.15 | n/a | 1 | Jul 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $1.38 | n/a | 2 | Oct 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2.5 | $0.0001 | n/a | 2 | Oct 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $116 | $58.33 | n/a | 59 | Sep 25, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $18.37 | n/a | 2 | Sep 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $7.22 | n/a | 1 | Sep 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $44.52 | n/a | 1 | Sep 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $110 | $595.66 | n/a | 43 | Feb 23, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $626 | $959.41 | n/a | 43 | Jan 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $57 | $8.08 | n/a | 9 | Dec 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $1.44 | n/a | 1 | Dec 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $113 | $122.27 | n/a | 9 | Nov 14, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $109.29 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $45.13 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $101.61 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $129 | $318.79 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 | $182.71 | n/a | 1 | Jul 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 → $2 | $0.000001 | n/a | 5 | Jun 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 | $16.68 | n/a | 2 | Feb 5, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $193 | $429.48 | n/a | 1 | Jan 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $157 | $402.94 | n/a | 1 | Jan 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 | $2.73 | n/a | 2 | Jan 4, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $20 | $3.88 | n/a | 8 | Nov 6, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 | $49.36 | n/a | 4 | Aug 5, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $40 | $5.72 | n/a | 4 | Jun 30, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $128.38 | n/a | 1 | Jun 29, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $0.0008 | n/a | 2 | Mar 20, 2012 |
Kodiak Sciences
Nov 13, 2026
Maintained: Buy
Price Target: $120 → $150
Current: $109.34
Upside: +37.19%
Scholar Rock Holding
Nov 12, 2026
Maintained: Buy
Price Target: $60
Current: $46.60
Upside: +28.76%
MBX Biosciences
Nov 10, 2026
Reiterated: Buy
Price Target: $90
Current: $57.72
Upside: +55.93%
Oruka Therapeutics
Nov 10, 2026
Reiterated: Buy
Price Target: $130
Current: $107.17
Upside: +21.30%
Moderna
Nov 9, 2026
Rated: Hold
Price Target: $150 → $225
Current: $248.69
Upside: -9.53%
Amgen
Nov 4, 2026
Reiterated: Buy
Price Target: $470 → $530
Current: $468.11
Upside: +13.22%
Pfizer
Nov 4, 2026
Reiterated: Hold
Price Target: $27 → $30
Current: $29.45
Upside: +1.87%
Vertex Pharmaceuticals
Nov 4, 2026
Reiterated: Buy
Price Target: $615 → $640
Current: $547.03
Upside: +17.00%
AbbVie
Nov 2, 2026
Rated: Hold
Price Target: $275 → $295
Current: $294.98
Upside: +0.01%
Inventiva
Nov 1, 2026
Reiterated: Buy
Price Target: $12
Current: $4.01
Upside: +199.25%
Oct 30, 2026
Rated: Buy
Price Target: $175 → $195
Current: $169.73
Upside: +14.89%
Oct 30, 2026
Rated: Buy
Price Target: $1,425 → $1,625
Current: $1,437.29
Upside: +13.06%
Oct 29, 2026
Rated: Buy
Price Target: $270 → $300
Current: $253.40
Upside: +18.39%
Oct 26, 2026
Reiterated: Buy
Price Target: $50
Current: $32.72
Upside: +52.84%
Oct 25, 2026
Reiterated: Buy
Price Target: $320
Current: $280.41
Upside: +14.12%
Oct 24, 2026
Reiterated: Buy
Price Target: $175
Current: $147.18
Upside: +18.90%
Oct 22, 2026
Rated: Buy
Price Target: $265
Current: $180.70
Upside: +46.65%
Oct 20, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $13.30
Upside: +163.16%
Oct 13, 2026
Reiterated: Buy
Price Target: $60
Current: $29.40
Upside: +104.08%
Oct 9, 2026
Reiterated: Buy
Price Target: $80
Current: $62.91
Upside: +27.17%
Sep 22, 2026
Rated: Buy
Price Target: $76
Current: $48.77
Upside: +55.83%
Sep 11, 2026
Initiated Coverage: Buy
Price Target: $55
Current: $31.84
Upside: +72.74%
Aug 13, 2026
Rated: Buy
Price Target: $65
Current: $50.53
Upside: +28.64%
Aug 7, 2026
Rated: Buy
Price Target: $25 → $34
Current: $19.73
Upside: +72.33%
Jun 15, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $16.54
Upside: +172.07%
Jun 2, 2026
Reiterated: Buy
Price Target: $45
Current: $8.04
Upside: +459.70%
May 12, 2026
Reiterated: Buy
Price Target: $6
Current: $1.12
Upside: +435.71%
Mar 17, 2026
Rated: Hold
Price Target: $18 → $13
Current: $31.52
Upside: -58.76%
Mar 5, 2026
Reiterated: Buy
Price Target: $3 → $20
Current: $2.16
Upside: +825.93%
Mar 3, 2026
Reiterated: Hold
Price Target: $10 → $7
Current: $4.29
Upside: +63.17%
Feb 25, 2026
Reiterated: Buy
Price Target: $7
Current: $3.11
Upside: +125.08%
Feb 17, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $23.25
Upside: +93.55%
Jan 7, 2026
Initiated Coverage: Buy
Price Target: $45 → $50
Current: $31.25
Upside: +60.00%
Jan 7, 2026
Initiated Coverage: Buy
Price Target: $50 → $35
Current: $26.42
Upside: +32.48%
Jan 6, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $0.9001
Upside: +788.79%
Jan 6, 2026
Initiated Coverage: Hold
Price Target: $30 → $28
Current: $25.81
Upside: +8.49%
Jan 6, 2026
Initiated Coverage: Buy
Price Target: $45 → $55
Current: $31.65
Upside: +73.78%
Jun 25, 2025
Reiterated: Hold
Price Target: $1.5 → $3.5
Current: $3.79
Upside: n/a
May 27, 2025
Downgraded: Hold
Price Target: $32 → $6
Current: $8.73
Upside: n/a
Mar 13, 2025
Reiterated: Buy
Price Target: $24 → $18
Current: $8.09
Upside: n/a
Mar 6, 2025
Reiterated: Buy
Price Target: $145 → $8
Current: $1.61
Upside: n/a
Oct 25, 2023
Downgraded: Hold
Price Target: $3 → $1
Current: $11.71
Upside: n/a
Mar 22, 2023
Reiterated: Buy
Price Target: $26
Current: $70.70
Upside: n/a
Dec 22, 2021
Downgraded: Hold
Price Target: $46 → $10
Current: $0.5993
Upside: n/a
Aug 10, 2021
Reiterated: Hold
Price Target: $45 → $15
Current: $3.68
Upside: n/a
Dec 21, 2020
Reiterated: Hold
Price Target: $10 → $7
Current: $22.37
Upside: n/a
Dec 21, 2018
Reiterated: Buy
Price Target: $40 → $31
Current: $22,005.00
Upside: n/a
Jul 8, 2018
Reiterated: Hold
Price Target: $1.5 → $1
Current: $1.09
Upside: n/a
Jul 8, 2018
Reiterated: Hold
Price Target: $3.5
Current: $1.05
Upside: n/a
Jul 8, 2018
Reiterated: Buy
Price Target: $22
Current: $4.15
Upside: n/a
Oct 27, 2017
Reiterated: Buy
Price Target: $47
Current: $1.38
Upside: n/a
Oct 2, 2017
Reiterated: Hold
Price Target: $2.5
Current: $0.0001
Upside: n/a
Sep 25, 2017
Reiterated: Buy
Price Target: $116
Current: $58.33
Upside: n/a
Sep 4, 2017
Reiterated: Buy
Price Target: $47
Current: $18.37
Upside: n/a
Sep 4, 2017
Reiterated: Buy
Price Target: $7
Current: $7.22
Upside: n/a
Sep 4, 2017
Reiterated: Buy
Price Target: $5
Current: $44.52
Upside: n/a
Feb 23, 2017
Reiterated: Hold
Price Target: $110
Current: $595.66
Upside: n/a
Jan 3, 2017
Reiterated: Buy
Price Target: $626
Current: $959.41
Upside: n/a
Dec 30, 2016
Reiterated: Hold
Price Target: $57
Current: $8.08
Upside: n/a
Dec 20, 2016
Reiterated: Buy
Price Target: $25
Current: $1.44
Upside: n/a
Nov 14, 2016
Reiterated: Buy
Price Target: $113
Current: $122.27
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $48
Current: $109.29
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $28
Current: $45.13
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $95
Current: $101.61
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $129
Current: $318.79
Upside: n/a
Jul 28, 2016
Reiterated: Buy
Price Target: $115
Current: $182.71
Upside: n/a
Jun 15, 2016
Downgraded: Hold
Price Target: $12 → $2
Current: $0.000001
Upside: n/a
Feb 5, 2016
Reiterated: Hold
Price Target: $15
Current: $16.68
Upside: n/a
Jan 25, 2016
Reiterated: Buy
Price Target: $193
Current: $429.48
Upside: n/a
Jan 25, 2016
Reiterated: Buy
Price Target: $157
Current: $402.94
Upside: n/a
Jan 4, 2016
Reiterated: Hold
Price Target: $7
Current: $2.73
Upside: n/a
Nov 6, 2015
Reiterated: Buy
Price Target: $35 → $20
Current: $3.88
Upside: n/a
Aug 5, 2015
Reiterated: Hold
Price Target: $9
Current: $49.36
Upside: n/a
Jun 30, 2014
Rated: Hold
Price Target: $40
Current: $5.72
Upside: n/a
Jun 29, 2012
Upgraded: Buy
Price Target: n/a
Current: $128.38
Upside: n/a
Mar 20, 2012
Reiterated: Buy
Price Target: $28
Current: $0.0008
Upside: n/a